IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NEA Management Company, LLC

Portfolio Profile

CIK: 0001512848 | TIMONIUM, MD

Investment Profile

Style

Deep Value

Turnover

Low

Orientation

Concentrated trader
$1.6B
AUM
26
Positions
89.82%
Top 10 Conc.
99.99%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Trevi Therapeutics, Inc.(TRVI)13,222,228$246.6M15.53%
2MBX Biosciences, Inc.(MBX)3,614,486$199.5M12.56%
3Monte Rosa Therapeutics, Inc.(GLUE)7,692,298$186.2M11.72%
4Celcuity Inc.(CELC)1,710,561$179.0M11.27%
5Spyglass Pharma, Inc.(SGP)7,392,301$164.6M10.36%

Sector Allocation

Latest filing, equity positions only

Healthcare80.48% · $1.3B
Unclassified14.95% · $237.4M
Consumer Defensive4.57% · $72.6M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare81.23%80.48%-0.75%
Unclassified14.51%14.95%+0.44%

AUM History

$1.3B | 46 pos.
$1.5B | 44 pos.
$1.6B | 44 pos.
$1.3B | 41 pos.
$1.8B | 42 pos.
$1.8B | 42 pos.
6
Savara, Inc.(SVRA)
24,471,264
$150.7M
9.49%
7Zenas BioPharma, Inc.(ZBIO)4,023,219$102.1M6.43%
8Coursera, Inc.(COUR)12,867,769$72.6M4.57%
9Aurinia Pharmaceuticals, Inc.(AUPH)3,969,834$67.4M4.24%
10Crispr Therapeutics AG(CRSP)1,058,570$57.7M3.64%
Consumer Defensive4.26%4.57%+0.31%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Small Cap46.62%69.05%+22.43%
Unclassified14.51%14.95%+0.44%
Mid Cap34.71%11.27%-23.44%
Micro Cap4.16%4.73%+0.57%
$1.3B | 38 pos.
$1.3B | 32 pos.
$1.8B | 29 pos.
$2.0B | 27 pos.
$1.8B | 26 pos.
$1.6B | 26 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
1
Closed
0
Increased
2
Decreased
23
Unchanged